Free Trial

Context Therapeutics (CNTX) Institutional Ownership

Context Therapeutics logo
$0.72 +0.02 (+2.86%)
As of 03:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Context Therapeutics (NASDAQ:CNTX)

Current
Institutional Ownership
Percentage
14.03%
Number of
Institutional Buyers
(last 12 months)
21
Total
Institutional Inflows
(last 12 months)
$45.68M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$3.76M
Get CNTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Context Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CNTX Institutional Buying and Selling by Quarter

Context Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2025Affinity Asset Advisors LLC518,025$339K0.0%-21.6%0.578%
8/13/2025Walleye Capital LLC132,786$87K0.0%-21.4%0.148%
5/16/2025Ally Bridge Group NY LLC1,157,448$708K0.6%-26.6%1.290%
5/15/2025 Landscape Capital Management L.L.C.41,216$25K0.0%-54.2%0.046%
5/14/2025Affinity Asset Advisors LLC660,589$404K0.0%-34.9%0.736%
2/17/2025Velan Capital Investment Management LP90,000$94K0.1%-93.0%0.120%
2/17/2025Shay Capital LLC50,000$52K0.0%N/A0.067%
2/17/2025MPM Bioimpact LLC14,705,882$15.44M2.2%N/A19.608%
2/17/2025Millennium Management LLC178,718$188K0.0%+24.2%0.238%
2/17/2025Citadel Advisors LLC29,900$31K0.0%N/A0.040%
2/17/2025Allostery Investments LP950,166$998K1.0%N/A1.267%
2/17/2025Ally Bridge Group NY LLC1,576,762$1.66M1.4%-10.3%2.102%
2/14/2025Jane Street Group LLC27,395$29K0.0%N/A0.037%
2/14/2025Northern Trust Corp113,565$119K0.0%-34.2%0.151%
2/14/2025 Blue Owl Capital Holdings LP6,357,928$6.68M1.6%+17.5%8.477%
2/13/2025Marshall Wace LLP203,286$213K0.0%N/A0.271%
2/13/2025Affinity Asset Advisors LLC1,015,340$1.07M0.1%-23.1%1.354%
2/13/2025Walleye Capital LLC166,306$175K0.0%+51.7%0.222%
2/13/2025Renaissance Technologies LLC338,435$355K0.0%+412.8%0.451%
2/13/2025ADAR1 Capital Management LLC351,094$369K0.1%-6.1%0.468%
2/12/2025 Landscape Capital Management L.L.C.90,000$94K0.0%N/A0.120%
2/12/2025 Geode Capital Management LLC628,729$661K0.0%+9.2%0.838%
2/12/2025 Franklin Resources Inc.4,003,380$4.20M0.0%+115.9%5.338%
1/17/2025 Clear Harbor Asset Management LLC57,804$61K0.0%+60.6%0.077%
11/27/2024 Franklin Resources Inc.1,853,988$3.69M0.0%N/A2.472%
11/16/2024 Geode Capital Management LLC575,899$1.13M0.0%-6.8%0.768%
11/15/2024 Y Intercept Hong Kong Ltd45,635$89K0.0%N/A0.061%
11/15/2024State Street Corp111,907$219K0.0%+21.5%0.149%
11/14/2024Ally Bridge Group NY LLC1,757,524$3.45M1.8%-6.8%2.343%
11/13/2024Great Point Partners LLC6,934,982$13.59M4.0%-6.5%9.247%
8/20/2024Nantahala Capital Management LLC1,935,484$3.88M0.2%N/A2.581%
8/16/2024Driehaus Capital Management LLC2,258,065$4.53M0.0%N/A3.011%
8/15/2024 Blue Owl Capital Holdings LP5,161,290$10.35M2.9%N/A6.882%
8/15/2024Affinity Asset Advisors LLC1,619,140$3.25M0.4%+392.4%2.159%
8/14/2024Great Point Partners LLC7,419,355$14.88M2.8%N/A9.893%
8/14/2024Ally Bridge Group NY LLC1,886,232$3.78M2.3%+159.8%2.515%
8/9/2024Renaissance Technologies LLC65,200$131K0.0%+63.4%0.087%
5/29/2024Opaleye Management Inc.1,108,357$1.53M0.3%+13.7%1.478%
2/15/2024Opaleye Management Inc.975,000$1.10M0.3%N/A6.107%
11/15/2023Affinity Asset Advisors LLC328,817$497K0.1%+22.9%2.059%
Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)

tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.

Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow
8/21/2023Affinity Asset Advisors LLC267,574$428K0.1%N/A1.675%
7/21/2023 Clear Harbor Asset Management LLC36,000$58K0.0%N/A0.225%
2/16/2023 AIGH Capital Management LLC1,143,745$745K0.2%-11.5%7.162%
2/14/2023swisspartners Ltd.180,000$119K0.2%+111.8%1.127%
11/14/2022Worth Venture Partners LLC322,628$358K0.2%+8.4%2.021%
11/1/2022swisspartners Ltd.85,000$94K0.1%+101.3%0.532%
8/13/2022 Virtu Financial LLC46,445$98K0.0%N/A0.291%
8/12/2022Affinity Asset Advisors LLC883,654$1.87M0.8%+13.6%5.535%
5/4/2022swisspartners Ltd.14,315$4.98M3.5%-66.1%0.090%
2/14/2022 Altium Capital Management LP493,531$1.31M0.4%N/A4.501%
2/11/2022QCM Cayman Ltd.14,041$37K0.2%N/A0.128%
2/10/2022 AIGH Capital Management LLC762,721$2.03M0.6%N/A6.955%
2/9/2022swisspartners Ltd.42,235$114K0.1%N/A0.385%
(Data available from 1/1/2016 forward)

CNTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CNTX shares?

During the previous two years, 25 institutional investors and hedge funds held shares of Context Therapeutics. The most heavily invested institutionals were MPM Bioimpact LLC ($15.44M), Great Point Partners LLC ($13.59M), Blue Owl Capital Holdings LP ($6.68M), Driehaus Capital Management LLC ($4.53M), Franklin Resources Inc. ($4.20M), Nantahala Capital Management LLC ($3.88M), and Opaleye Management Inc. ($1.53M).Learn more on Context Therapeutics' institutional investors.

What percentage of Context Therapeutics' stock is owned by institutional investors?

14.03% of Context Therapeutics' stock is owned by institutional investors. Learn more on CNTX's institutional investor holdings.

Which institutional investors have been buying Context Therapeutics' stock?

Of the 22 institutional investors that purchased Context Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: MPM Bioimpact LLC ($14.71M), Great Point Partners LLC ($7.42M), Blue Owl Capital Holdings LP ($6.11M), Franklin Resources Inc. ($4.00M), Driehaus Capital Management LLC ($2.26M), Nantahala Capital Management LLC ($1.94M), and Affinity Asset Advisors LLC ($1.62M).

How much institutional buying is happening at Context Therapeutics?

Institutional investors have bought a total of 32,155,799 shares in the last 24 months. This purchase volume represents approximately $45.68M in transactions.

Which of Context Therapeutics' major shareholders have been selling company stock?

Of the 9 institutional investors that sold Context Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Velan Capital Investment Management LP ($1.20M), Affinity Asset Advisors LLC ($803.13K), Ally Bridge Group NY LLC ($728.78K), Great Point Partners LLC ($484.37K), Northern Trust Corp ($58.95K), Landscape Capital Management L.L.C. ($48.78K), and Geode Capital Management LLC ($42.28K).

How much institutional selling is happening at Context Therapeutics?

Institutional investors have sold a total of 3,425,528 shares in the last 24 months. This volume of shares sold represents approximately $3.76M in transactions.



This page (NASDAQ:CNTX) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners